Ureteral obstruction reverses glomerular proliferation in immune complex glomerulonephritis

Area of Science:

• Nephrology
• Immunology
• Pathology

Background:

• Immune complex glomerulonephritis is a progressive kidney disease often seen in lupus erythematosus.
• Ureteral obstruction is a condition that can affect kidney function and inflammation.

Purpose of the Study:

• To investigate the impact of ureteral obstruction on immune complex glomerulonephritis in a murine lupus model.
• To explore the role of renal eicosanoids in the observed changes in glomerulonephritis following ureteral obstruction.

Main Methods:

• Murine lupus model with induced unilateral ureteral obstruction for 8 days.
• Computer-assisted morphometry to measure glomerular mesangial area.
• Measurement of IgG, C3, extracellular matrix components, and eicosanoids (PGE2, 6-keto-PGF1alpha, TxB2).
• Pharmacological intervention using cyclooxygenase inhibitor (indomethacin) and thromboxane synthetase inhibitor (CV-4151).

Main Results:

• Unilateral ureteral obstruction significantly decreased glomerular mesangial area and reduced IgG, C3, and extracellular matrix deposition in the obstructed kidney.
• Renal concentrations of prostaglandin E2 (PGE2) and 6-keto-prostaglandin F1alpha (6-keto-PGF1alpha) were significantly elevated in obstructed kidneys.
• Indomethacin treatment abolished the protective effect of ureteral obstruction on mesangial expansion, while thromboxane synthetase inhibition had no significant effect.

Conclusions:

• Unilateral ureteral obstruction rapidly reduces mesangial expansion in immune complex glomerulonephritis.
• Vasodilatory eicosanoids, specifically PGE2 and PGI2, play a significant role in the amelioration of glomerular histology.
• These findings suggest a potential therapeutic avenue involving modulation of eicosanoid pathways in glomerulonephritis.